800.850.4306
  • Facebook
  • Twitter
  • LinkedIn
  • Facebook
  • Twitter
  • LinkedIn
  • News
  • Media
  • About Us
  • Contact
Biologics by McKesson
  • Patients
  • Providers
  • Biopharma
    • Biologics Rare and Orphan Care
  • Payers
Select Page

Ibrance® (palbociclib) approved for ER+, HER2- advanced breast cancer, available immediately at Biologics, Inc.

Feb 5, 2015 | Archive

CARY, NC — February 5, 2015 — Biologics, an integrated oncology services company, is pleased to announce that Biologics has been selected as a specialty pharmacy authorized to dispense Ibrance (palbociclib). Ibrance was approved by the U.S. Food and Drug...

Recent Posts

  • Video Transcript: Patient Spotlight – Cherie T.
  • Video Transcript: Patient Spotlight – Nicole B.
  • Video Transcript: Patient Spotlight – Karen I.
  • Video Transcript: Patient Spotlight – Larry H.
  • Video Transcript: Patient Spotlight – Erica R.

Archives

  • April 2021
  • March 2021
  • January 2021
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • January 2020
  • August 2019
  • July 2019
  • March 2019
  • December 2018
  • September 2018
  • July 2018
  • June 2018
  • May 2018
  • February 2018
  • January 2018
  • June 2017
  • March 2017
  • February 2016
  • November 2015
  • February 2015
  • December 2014
Biologics by McKesson logo

13000 Weston Parkway
Suite 105
Cary, NC 27513
T. 800.850.4306*

 

Legal
Privacy Notice
Terms of Use

For Patients
Privacy Practices (pdf)
Patient’s Rights (pdf)

Learn more about McKesson

URAC accreditation seal Biologics 2023 ACHC Gold Seal Accreditation ACHC Blue Seal Accreditation in Oncology

 

Home
Patients
Providers
Payers
Biopharma
News
Careers
About Us
Leadership
Contact
Resources

© 2019 McKesson Corporation. All Rights Reserved.